Lawrence Nathan Shulman, MD

faculty photo
Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Abramson Cancer Center
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine
South Pavilion, 12-105
Philadelphia, PA 19104
B.A. (Organic Chemistry)
Syracuse University, 1971.
M.D. (Medicine)
Harvard Medical School, 1975.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Lawrence N. Shulman, MD, is the Associate Director for Special Projects of the Abramson Cancer Center at the University of Pennsylvania, and Director of the Center for Global Cancer Medicine.

Dr. Shulman is immediate past Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. He is the former Chair of the American Society of Clinical Oncology Quality of Care Committee and the Commission on Cancer’s Quality Integration Committee. In this regard, Dr. Shulman serves as Senior Oncology Advisor to the non-profit organization Partners In Health (PIH). The PIH mission includes the establishment of national cancer treatment programs with the Ministries of Health in Rwanda, Lesotho, and Haiti, programs for which he plays a seminal leadership role. He sits on the Vice Chancellor’s Advisory Council for Rwanda’s University for Global Health Equity. In addition, he helps to lead the development of the national oncology program in Botswana through the Botswana-UPenn Partnership.

Dr. Shulman is a former member of ASCO’s International Affairs Committee and their Task Force on Global Oncology as an Academic Career. He led the World Health Organization’s review and revision of their Essential Medicines for Cancer from 2014-2017.

He received his MD from Harvard Medical School, and trained in Hematology and Oncology at the Beth Israel Hospital in Boston, MA.

Description of Research Expertise

His research includes innovations in cancer care delivery, both in the US and in resource constrained settings, including Rwanda, Botswana and Haiti.

Selected Publications

Parikh RB, Schriver E, Ferrell WJ, Wakim J, Williamson J, Khan N, Kopinsky M, Balachandran M, Gabriel PE, Schuchter LM, Patel MS, Shulman LN, Manz CR: Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial. JCO Oncol Pract Oct 10 2023 Notes: doi: 10.1200/OP.23.00048. Epub ahead of print.

Lipsyc-Sharf M, Ballman KV, Campbell JD, Muss HB, Perez EA, Shulman LN, Carey LA, Partridge AH, Warner ET: Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival. JAMA Netw Open 6(10), Oct 2 2023 Notes: doi: 10.1001/jamanetworkopen.2023.39584.

Jenssen BP, Schnoll R, Beidas RS, Bekelman J, Bauer AM, Evers-Casey S, Fisher T, Scott C, Nicoloso J, Gabriel P, Asch DA, Buttenheim AM, Chen J, Melo J, Grant D, Horst M, Oyer R, Shulman LN, Clifton ABW, Lieberman A, Salam T, Rendle KA, Chaiyachati KH, Shelton RC, Fayanju O, Wileyto EP, Ware S, Blumenthal D, Ragusano D, Leone FT: Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke. J Clin Oncol 41(28): 4511-4521, Oct 1 2023 Notes: doi: 10.1200/JCO.23.00355. Epub 2023 Jul 19.

Pace LE, Fata AM, Cubaka VK, Nsemgiyumva T, Uwihaye JD, Stauber C, Dusengimana JV, Bhangdia K, Shulman LN, Revette A, Hagenimana M, Uwinkindi F, Rwamuza E: Patients' experiences undergoing breast evaluation in Rwanda's Women's Cancer Early Detection Program. Breast Cancer Res Treat Aug 30 2023 Notes: doi: 10.1007/s10549-023-07076-x. Epub ahead of print.

Aggarwal C, Marmarelis ME, Hwang WT, Scholes DG, McWilliams TL, Singh AP, Sun L, Kosteva J, Costello MR, Cohen RB, Langer CJ, Doucette A, Gabriel PN, Shulman LN, Rendle KA, Thompson JC, Bekelman JE, Carpenter EL: Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer. JCO Precis Oncol Jul 2023 Notes: doi: 10.1200/PO.23.00191.

Pace LE, Hagenimana M, Dusengimana JV, Balinda JP, Benewe O, Rugema V, de Dieu Uwihaye J, Fata A, Shyirambere C, Shulman LN, Keating NL, Uwinkindi F: Implementation research: including breast examinations in a cervical cancer screening programme, Rwanda. Bull World Health Organ 101(7): 478-486, Jul 1 2023 Notes: doi: 10.2471/BLT.22.289599. Epub 2023 May 26.

Davies L, Milner DA Jr, Shulman LN, Kyokunda L, Bedada A, Vuylsteke P, Masalu N, Jackson P, Jennings N, Odunlami A, Mtshali P, Dugan U: Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities. JCO Glob Oncol 9, Jun 2023 Notes: doi: 10.1200/GO.22.00203.

Sedhom R, Shulman LN, Parikh RB: Precision Palliative Care as a Pragmatic Solution for a Care Delivery Problem. J Clin Oncol 41(16): 2888-2892, Jun 1 2023 Notes: doi: 10.1200/JCO.22.02532. Epub 2023 Apr 21.

Gabriel PE, Singh AP, Shulman LN: Re-envisioning the Paradigm for Oncology Electronic Health Record Documentation by Paying for What Matters for Patients, Quality, and Research. JAMA Oncol 9(3): 299-300, Mar 1 2023 Notes: doi: 10.1001/jamaoncol.2022.6842.

Manz CR, Zhang Y, Chen K, Long Q, Small DS, Evans CN, Chivers C, Regli SH, Hanson CW, Bekelman JE, Braun J, Rareshide CAL, O'Connor N, Kumar P, Schuchter LM, Shulman LN, Patel MS, Parikh RB: Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 9(3): 414-418, Mar 1 2023 Notes: 10.1001/jamaoncol.2022.6303.

back to top
Last updated: 10/30/2023
The Trustees of the University of Pennsylvania